Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for NCNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 26.89M
March 31, 2026 29.50M
December 31, 2025 32.72M
September 30, 2025 34.90M
June 30, 2025 10.12M
March 31, 2025 5.388M
December 31, 2024 7.457M
September 30, 2024 5.832M
June 30, 2024 4.804M
March 31, 2024 12.80M
December 31, 2023 18.98M
September 30, 2023 26.58M
June 30, 2023 34.81M
March 31, 2023 39.26M
December 31, 2022 46.31M
September 30, 2022 58.82M
June 30, 2022 68.05M
Date Value
March 31, 2022 77.31M
December 31, 2021 88.78M
September 30, 2021 104.43M
June 30, 2021 116.31M
March 31, 2021 126.19M
December 31, 2020 135.64M
September 30, 2020 142.56M
June 30, 2020 70.59M
March 31, 2020 74.93M
December 31, 2019 84.15M
September 30, 2019 86.52M
June 30, 2019 92.93M
March 31, 2019 99.88M
December 31, 2018 103.92M
September 30, 2018 110.68M
June 30, 2018 114.48M
March 31, 2018 122.67M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
Mereo BioPharma Group Plc 28.65M
BioNTech SE 20.30B
Silence Therapeutics Plc 38.47M
Compass Pathways Plc 84.53M

Shareholders Equity (Quarterly) Related Metrics